Article
Prevalence and Risk Factors of Rifampicin Resistant Mycobacterium Tuberculosis among Human Immune Virus Sero-Positive Patients in South Western Uganda
2023-11-15
Abstract excerpt
<title>Abstract</title> <p>Background Tuberculosis is treated using rifampicin and isoniazid as the first line drugs, with rifampicin playing a pivotal role in the effective treatment of tuberculosis. However, resistance to rifampicin is common and used as a valuable surrogate marker for multi-drug resistant tuberculosis (MDR-TB). Furthermore, HIV co-infection complicates the management of PTB. Methods Across s...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- a1055b87-3f46-5017-a5a5-f748d489a61c
- DOI
- 10.21203/rs.3.rs-3486350/v1
